Akums Drugs and Pharmaceuticals has made a major landmark by receiving a 20-year patent for its revolutionary 'tablet-in-tablet' technology aimed at treating Gastroesophageal Reflux Disease (GERD).
MedGenome, a leading global genomics-based diagnostics and research company, has made a majority investment in Gujarat-headquartered Green Cross Genetics Lab, strengthening its footprint in India’s growing diagnostics market...
Amgen has declared that new findings from its cardiovascular portfolio, which includes late-breaking results from the phase 3 VESALIUS-CV clinical trial of Repatha (evolocumab), will be showcased at the American Heart Association (AHA) Scientific
Alkem Foundation, the Corporate Social Responsibility (CSR) arm of Alkem Laboratories Ltd., has announced a strategic collaboration with the Indian Institute of Technology Bombay
Roche announced that it has acquired the CE mark for Elecsys Dengue Ag, their high-throughput, fully-automated immunoassay system that helps the diagnosis of acute dengue virus infections.
Helex, a therapeutics startup operating across the US and India, has secured an oversubscribed $3.5 million Seed round led by pi Ventures, with participation from Bluehill Capital, SOSV, and a network of global investors. This latest investment bring
Autoimmune diseases represent a significant and growing global health issue, affecting approximately 10% of the population and imposing a considerable burden on both patients and healthcare systems. Despite progress in therapeutic innovations, there
The US Food and Drug Administration (FDA) has tentatively approved Amneal Pharmaceuticals Inc.'s Abbreviated New Drug Application (ANDA) for beclomethasone dipropionate HFA inhalation aerosol (40 mcg/actuation and 80 mcg/actuation), according to the
FUJIFILM India has recently introduced its new healthcare technology, FW 500 Clinical Chemistry Analyzer, which consolidates In-vitro Diagnostics. The FW500 offers both the expertise in dry chemistry Fujifilm has developed over 40 years plus...
In an interaction with Thiruamuthan, Assistant Editor of India Pharma Outlook, Ankush Kapoor, Founder & CEO of PharmNXT Biotech, discusses how India’s biotech ecosystem is redefining bioprocessing through Single-Use Technologies, Defined Tubing Routi
, CDSCO.jpg)